triamcinolone has been researched along with Vitreoretinopathy, Proliferative in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyer, L; Michel, G; Naoun, KO | 1 |
| Haritoglou, C; Kampik, A | 2 |
| Ashton, P; Berger, AS; Cheng, CK; Crooks, PA; Cynkowska, G; Cynkowski, T; Jaffe, GJ; Pearson, PA | 1 |
| Ashton, P; Chen, SN; Guo, H; Hainsworth, DP; Jaffe, GJ; Khawly, JA; Yang, CS | 1 |
| Foster, RE; Lewis, H; Schwendeman, SP; Zhou, T | 1 |
| Hu, D; Hui, YN | 1 |
7 other study(ies) available for triamcinolone and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
[Active drainage combined with air-fluid exchange for silicone oil removal: advantages and long-term follow-up].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Air; Emulsions; Female; Follow-Up Studies; Humans; Infusion Pumps, Implantable; Injections; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Recurrence; Retinal Detachment; Silicone Oils; Suction; Triamcinolone; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2008 |
[Surgical therapy of diabetic retinopathy].
Topics: Blindness; Blood Glucose; Diabetic Retinopathy; Fluorescein Angiography; Humans; Laser Coagulation; Macular Edema; Retina; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vitreoretinopathy, Proliferative | 2005 |
[Staining techniques in macular surgery].
Topics: Drug-Related Side Effects and Adverse Reactions; Epiretinal Membrane; Humans; Indocyanine Green; Retinal Perforations; Sensitivity and Specificity; Triamcinolone; Trypan Blue; Vitreoretinopathy, Proliferative | 2006 |
Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
Topics: Animals; Antimetabolites; Delayed-Action Preparations; Dexamethasone; Disease Models, Animal; Drug Combinations; Drug Delivery Systems; Drug Implants; Female; Fluorouracil; Glucocorticoids; Male; Rabbits; Retinal Detachment; Triamcinolone; Vitreoretinopathy, Proliferative; Vitreous Body | 1996 |
An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.
Topics: Animals; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Disease Models, Animal; Drug Implants; Drug Therapy, Combination; Electroretinography; Fluorouracil; Glucocorticoids; Immunosuppressive Agents; Injections; Rabbits; Treatment Outcome; Triamcinolone; Vitreoretinopathy, Proliferative; Vitreous Body | 1998 |
Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.
Topics: Chromatography, High Pressure Liquid; Drug Implants; Eye; Humans; Microscopy, Electron, Scanning; Molecular Weight; Particle Size; Polymers; Recombinant Proteins; Tissue Plasminogen Activator; Triamcinolone; Uridine; Vitreoretinopathy, Proliferative | 1998 |
Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease.
Topics: Animals; Autoradiography; Cell Division; Daunorubicin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Female; Inflammation; Macrophages; Male; Rabbits; Retinal Detachment; Triamcinolone; Vitreoretinopathy, Proliferative | 1999 |